Header Logo

Connection

Laurel Habel to Female

Back to Details
This is a "connection" page, showing publications Laurel Habel has written about Female.
Laurel Habel
Connection Strength
2.778
Female
  1. Examination of fully automated mammographic density measures using LIBRA and breast cancer risk in a cohort of 21,000 non-Hispanic white women. Breast Cancer Res. 2023 08 06; 25(1):92.
    View in: PubMed
    Score: 0.077
  2. Identification of 31 loci for mammographic density phenotypes and their associations with breast cancer risk. Nat Commun. 2020 10 09; 11(1):5116.
    View in: PubMed
    Score: 0.063
  3. Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence. Breast Cancer Res Treat. 2020 Feb; 180(1):219-226.
    View in: PubMed
    Score: 0.060
  4. Blood pressure lowering medication initiation and fracture risk: a SWAN pharmacoepidemiology study. Arch Osteoporos. 2019 06 28; 14(1):73.
    View in: PubMed
    Score: 0.058
  5. Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives. Cancer Res. 2017 12 01; 77(23):6770-6776.
    View in: PubMed
    Score: 0.052
  6. Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Res Treat. 2018 02; 167(3):751-759.
    View in: PubMed
    Score: 0.051
  7. Age at Menarche and Late Adolescent Adiposity Associated with Mammographic Density on Processed Digital Mammograms in 24,840 Women. Cancer Epidemiol Biomarkers Prev. 2017 09; 26(9):1450-1458.
    View in: PubMed
    Score: 0.050
  8. The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening. J Prim Care Community Health. 2017 Apr; 8(2):55-62.
    View in: PubMed
    Score: 0.048
  9. Case-control study of mammographic density and breast cancer risk using processed digital mammograms. Breast Cancer Res. 2016 05 21; 18(1):53.
    View in: PubMed
    Score: 0.047
  10. Pioglitazone Use and Risk of Bladder Cancer--Reply. JAMA. 2015 Dec 15; 314(23):2568-9.
    View in: PubMed
    Score: 0.045
  11. Metformin use and lung cancer risk in patients with diabetes. Cancer Prev Res (Phila). 2015 Feb; 8(2):174-9.
    View in: PubMed
    Score: 0.043
  12. Association between high-sensitivity C-reactive protein (hsCRP) and change in mammographic density over time in the SWAN mammographic density subcohort. Cancer Causes Control. 2015 Mar; 26(3):431-42.
    View in: PubMed
    Score: 0.042
  13. Reply to L. Cabel et al. J Clin Oncol. 2015 Jan 20; 33(3):292-3.
    View in: PubMed
    Score: 0.042
  14. Distant invasive breast cancer recurrence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer diagnosed from 2000 to 2006: a cohort from an integrated health care delivery system. J Clin Oncol. 2014 Jul 10; 32(20):2151-8.
    View in: PubMed
    Score: 0.041
  15. Complications of herpes zoster in cancer patients. Scand J Infect Dis. 2014 Jul; 46(7):528-32.
    View in: PubMed
    Score: 0.040
  16. Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy. Obstet Gynecol. 2014 Jan; 123(1):65-72.
    View in: PubMed
    Score: 0.039
  17. Antidepressants and testicular cancer. Cancer Causes Control. 2014 Feb; 25(2):251-8.
    View in: PubMed
    Score: 0.039
  18. Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes. Diabetes Care. 2013 Dec; 36(12):3953-60.
    View in: PubMed
    Score: 0.039
  19. Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ. Breast Cancer Res Treat. 2013 Jun; 139(2):453-60.
    View in: PubMed
    Score: 0.038
  20. HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease. Breast Cancer Res. 2013 Mar 14; 15(2):R24.
    View in: PubMed
    Score: 0.037
  21. The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):82-90.
    View in: PubMed
    Score: 0.036
  22. Antihypertensive drugs and lip cancer in non-Hispanic whites. Arch Intern Med. 2012 Sep 10; 172(16):1246-51.
    View in: PubMed
    Score: 0.036
  23. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA. 2011 Dec 28; 306(24):2673-83.
    View in: PubMed
    Score: 0.034
  24. Re: a case-control study of levothyroxine and the risk of colorectal cancer. J Natl Cancer Inst. 2011 Nov 02; 103(21):1637-9.
    View in: PubMed
    Score: 0.034
  25. Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care. 2011 Apr; 34(4):923-9.
    View in: PubMed
    Score: 0.033
  26. Metabolic syndrome and mammographic density: the Study of Women's Health Across the Nation. Int J Cancer. 2011 Oct 01; 129(7):1699-707.
    View in: PubMed
    Score: 0.033
  27. Norepinephrine antagonists and cancer risk. Int J Cancer. 2011 Feb 01; 128(3):737-8; author reply 739.
    View in: PubMed
    Score: 0.032
  28. Mammographic density and risk of second breast cancer after ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2488-95.
    View in: PubMed
    Score: 0.032
  29. Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories. J Clin Oncol. 2010 Oct 01; 28(28):4300-6.
    View in: PubMed
    Score: 0.031
  30. Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans. Am J Manag Care. 2010 May; 16(5):351-60.
    View in: PubMed
    Score: 0.031
  31. Physical activity and change in mammographic density: the Study of Women's Health Across the Nation. Am J Epidemiol. 2010 May 01; 171(9):960-8.
    View in: PubMed
    Score: 0.030
  32. Active, but not passive cigarette smoking was inversely associated with mammographic density. Cancer Causes Control. 2010 Feb; 21(2):301-11.
    View in: PubMed
    Score: 0.030
  33. Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened. Cancer Causes Control. 2009 Dec; 20(10):1821-35.
    View in: PubMed
    Score: 0.030
  34. Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. Am J Surg Pathol. 2009 Dec; 33(12):1802-8.
    View in: PubMed
    Score: 0.030
  35. Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Breast Cancer Res. 2009; 11(6):R85.
    View in: PubMed
    Score: 0.030
  36. Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity. Int J Cancer. 2009 Nov 01; 125(9):2173-8.
    View in: PubMed
    Score: 0.030
  37. Mothers of children diagnosed with attention-deficit/hyperactivity disorder: health conditions and medical care utilization in periods before and after birth of the child. Med Care. 2009 Jan; 47(1):105-14.
    View in: PubMed
    Score: 0.028
  38. Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology. 2008 Dec; 135(6):1914-23, 1923.e1.
    View in: PubMed
    Score: 0.027
  39. Pharmaceuticals that cause mammary gland tumors in animals: findings in women. Breast Cancer Res Treat. 2009 Jul; 116(1):187-94.
    View in: PubMed
    Score: 0.027
  40. Erratum: Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients. Pharmacoepidemiol Drug Saf. 2008 Jul; 17(7):751.
    View in: PubMed
    Score: 0.027
  41. Physical activity and mammographic density in a cohort of midlife women. Med Sci Sports Exerc. 2008 Mar; 40(3):451-6.
    View in: PubMed
    Score: 0.026
  42. Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf. 2008 Jan; 17(1):27-36.
    View in: PubMed
    Score: 0.026
  43. Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN). Breast Cancer Res Treat. 2008 Nov; 112(1):165-74.
    View in: PubMed
    Score: 0.026
  44. Medical therapy for diabetes is associated with increased use of lower endoscopy. Pharmacoepidemiol Drug Saf. 2007 Nov; 16(11):1195-202.
    View in: PubMed
    Score: 0.026
  45. Mammographic density in a multiethnic cohort. Menopause. 2007 Sep-Oct; 14(5):891-9.
    View in: PubMed
    Score: 0.025
  46. Antibiotics and breast cancer. Cancer Epidemiol Biomarkers Prev. 2007 Jun; 16(6):1323.
    View in: PubMed
    Score: 0.025
  47. Antibiotics and risk of breast cancer: up to 9 years of follow-up of 2.1 million women. Cancer Epidemiol Biomarkers Prev. 2006 Nov; 15(11):2102-6.
    View in: PubMed
    Score: 0.024
  48. Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity. Arch Pediatr Adolesc Med. 2006 Oct; 160(10):1063-9.
    View in: PubMed
    Score: 0.024
  49. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res. 2006; 8(3):R25.
    View in: PubMed
    Score: 0.023
  50. Use of raloxifene among women with a history of breast cancer. Breast Cancer Res Treat. 2006 Mar; 96(2):123-9.
    View in: PubMed
    Score: 0.023
  51. Treatment with stimulants among youths in a large California health plan. J Child Adolesc Psychopharmacol. 2005 Feb; 15(1):62-7.
    View in: PubMed
    Score: 0.021
  52. Mammographic density and breast cancer after ductal carcinoma in situ. J Natl Cancer Inst. 2004 Oct 06; 96(19):1467-72.
    View in: PubMed
    Score: 0.021
  53. Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system. PLoS One. 2024; 19(6):e0303303.
    View in: PubMed
    Score: 0.020
  54. Mammographic density mediates the protective effect of early-life body size on breast cancer risk. Nat Commun. 2024 May 13; 15(1):4021.
    View in: PubMed
    Score: 0.020
  55. Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational Study. Radiology. 2023 06; 307(5):e222733.
    View in: PubMed
    Score: 0.019
  56. Breast Cancer Recurrence by Subtype in a Diverse, Contemporary Cohort of Young Women. J Am Coll Surg. 2023 07 01; 237(1):13-23.
    View in: PubMed
    Score: 0.019
  57. MiXcan: a framework for cell-type-aware transcriptome-wide association studies with an application to breast cancer. Nat Commun. 2023 Jan 23; 14(1):377.
    View in: PubMed
    Score: 0.019
  58. Anti-Müllerian hormone levels and breast cancer risk in the study of women's health across the nation. Cancer Causes Control. 2022 Aug; 33(8):1039-1046.
    View in: PubMed
    Score: 0.018
  59. Telehealth for Preoperative Evaluation of Patients With Breast Cancer During the COVID-19 Pandemic. Perm J. 2022 06 29; 26(2):54-63.
    View in: PubMed
    Score: 0.018
  60. Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci. Breast Cancer Res. 2022 04 12; 24(1):27.
    View in: PubMed
    Score: 0.018
  61. Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study. Breast Cancer Res Treat. 2022 May; 193(1):225-235.
    View in: PubMed
    Score: 0.017
  62. CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis. 2002 Mar; 23(3):419-24.
    View in: PubMed
    Score: 0.017
  63. Prescription medications for sleep disturbances among midlife women during 2 years of follow-up: a SWAN retrospective cohort study. BMJ Open. 2021 05 11; 11(5):e045074.
    View in: PubMed
    Score: 0.016
  64. Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts. Nat Commun. 2021 02 12; 12(1):970.
    View in: PubMed
    Score: 0.016
  65. Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020 09 04; 11(1):4423.
    View in: PubMed
    Score: 0.016
  66. Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative. Oncologist. 2020 08; 25(8):712-721.
    View in: PubMed
    Score: 0.015
  67. Alcohol and Tobacco Use in Relation to Mammographic Density in 23,456 Women. Cancer Epidemiol Biomarkers Prev. 2020 05; 29(5):1039-1048.
    View in: PubMed
    Score: 0.015
  68. Barbiturates and lung cancer: a re-evaluation. Int J Epidemiol. 1999 Jun; 28(3):375-9.
    View in: PubMed
    Score: 0.014
  69. Risk of recurrence after ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 1998 Aug; 7(8):689-96.
    View in: PubMed
    Score: 0.014
  70. Risk factors for incident and recurrent condylomata acuminata among women. A population-based study. Sex Transm Dis. 1998 Jul; 25(6):285-92.
    View in: PubMed
    Score: 0.013
  71. Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis. Cancer Causes Control. 2018 01; 29(1):143-156.
    View in: PubMed
    Score: 0.013
  72. Hydrochlorothiazide use is strongly associated with risk of lip cancer. J Intern Med. 2017 10; 282(4):322-331.
    View in: PubMed
    Score: 0.013
  73. Statin use and risk of multiple myeloma: An analysis from the cancer research network. Int J Cancer. 2017 08 01; 141(3):480-487.
    View in: PubMed
    Score: 0.012
  74. Feasibility of collecting tumor samples of breast cancer patients diagnosed up to 50 years ago in the Child Health and Development Studies. J Dev Orig Health Dis. 2017 Jun; 8(3):331-336.
    View in: PubMed
    Score: 0.012
  75. Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN). J Am Heart Assoc. 2017 Feb 23; 6(3).
    View in: PubMed
    Score: 0.012
  76. Oncologist and organizational factors associated with variation in breast cancer multigene testing. Breast Cancer Res Treat. 2017 May; 163(1):167-176.
    View in: PubMed
    Score: 0.012
  77. Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies. Cancer Res. 2016 09 15; 76(18):5415-22.
    View in: PubMed
    Score: 0.012
  78. Oral contraceptive use and risk of breast cancer in middle-aged women. Am J Epidemiol. 1996 Jul 15; 144(2):161-4.
    View in: PubMed
    Score: 0.012
  79. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016 08 10; 34(23):2743-9.
    View in: PubMed
    Score: 0.012
  80. Breast cancer multigene testing trends and impact on chemotherapy use. Am J Manag Care. 2016 05 01; 22(5):e153-60.
    View in: PubMed
    Score: 0.012
  81. Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen. Breast Cancer Res Treat. 2016 Apr; 156(2):379-89.
    View in: PubMed
    Score: 0.012
  82. Identification of Associations Between Prescribed Medications and Cancer: A Nationwide Screening Study. EBioMedicine. 2016 May; 7:73-9.
    View in: PubMed
    Score: 0.012
  83. Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community. Breast Cancer Res Treat. 2016 Feb; 155(3):541-9.
    View in: PubMed
    Score: 0.011
  84. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors. J Natl Cancer Inst. 2016 Mar; 108(3).
    View in: PubMed
    Score: 0.011
  85. Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes. JAMA. 2015 Jul 21; 314(3):265-77.
    View in: PubMed
    Score: 0.011
  86. Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S502-8.
    View in: PubMed
    Score: 0.011
  87. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.011
  88. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
    View in: PubMed
    Score: 0.011
  89. A hybrid approach to identify subsequent breast cancer using pathology and automated health information data. Med Care. 2015 Apr; 53(4):380-5.
    View in: PubMed
    Score: 0.011
  90. Racial/ethnic and socioeconomic differences in short-term breast cancer survival among women in an integrated health system. Am J Public Health. 2015 May; 105(5):938-46.
    View in: PubMed
    Score: 0.011
  91. Occupation and breast cancer risk in middle-aged women. J Occup Environ Med. 1995 Mar; 37(3):349-56.
    View in: PubMed
    Score: 0.011
  92. Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ. Ann Surg Oncol. 2014 Nov; 21(12):3766-73.
    View in: PubMed
    Score: 0.010
  93. Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Med Care. 2014 May; 52(5):e30-8.
    View in: PubMed
    Score: 0.010
  94. Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer. Pharmacoepidemiol Drug Saf. 2014 Jun; 23(6):636-45.
    View in: PubMed
    Score: 0.010
  95. Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99.
    View in: PubMed
    Score: 0.010
  96. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):714-24.
    View in: PubMed
    Score: 0.010
  97. Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
    View in: PubMed
    Score: 0.010
  98. Hormone receptors and breast cancer. Epidemiol Rev. 1993; 15(1):209-19.
    View in: PubMed
    Score: 0.009
  99. Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative. Cancer Epidemiol Biomarkers Prev. 2013 Mar; 22(3):365-73.
    View in: PubMed
    Score: 0.009
  100. Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat. 2013 Jan; 137(1):247-60.
    View in: PubMed
    Score: 0.009
  101. Utilization of HER2 genetic testing in a multi-institutional observational study. Am J Manag Care. 2012 Nov; 18(11):704-12.
    View in: PubMed
    Score: 0.009
  102. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat. 2012 Nov; 136(2):521-33.
    View in: PubMed
    Score: 0.009
  103. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012 Sep 05; 104(17):1293-305.
    View in: PubMed
    Score: 0.009
  104. Racial and ethnic differences in adjuvant hormonal therapy use. J Womens Health (Larchmt). 2012 Sep; 21(9):950-8.
    View in: PubMed
    Score: 0.009
  105. Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS. J Natl Cancer Inst. 2012 Apr 18; 104(8):614-21.
    View in: PubMed
    Score: 0.009
  106. Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev. 2012 Apr; 21(4):673-80.
    View in: PubMed
    Score: 0.009
  107. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet. 2012 Mar 03; 379(9818):823-32.
    View in: PubMed
    Score: 0.009
  108. Risk of cancer in patients exposed to gabapentin in two electronic medical record systems. Pharmacoepidemiol Drug Saf. 2012 Feb; 21(2):214-25.
    View in: PubMed
    Score: 0.009
  109. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med. 2011 Nov 17; 365(20):1896-904.
    View in: PubMed
    Score: 0.008
  110. Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2012 Jan; 131(2):607-17.
    View in: PubMed
    Score: 0.008
  111. Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women. Cancer Causes Control. 2011 Oct; 22(10):1415-24.
    View in: PubMed
    Score: 0.008
  112. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2011 Nov; 130(1):195-205.
    View in: PubMed
    Score: 0.008
  113. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat. 2011 Sep; 129(2):549-56.
    View in: PubMed
    Score: 0.008
  114. A method to estimate off-schedule observations in a longitudinal study. Ann Epidemiol. 2011 Apr; 21(4):297-303.
    View in: PubMed
    Score: 0.008
  115. Serial glycosylated hemoglobin levels and risk of colorectal neoplasia among patients with type 2 diabetes mellitus. Cancer Epidemiol Biomarkers Prev. 2010 Dec; 19(12):3027-36.
    View in: PubMed
    Score: 0.008
  116. Lipophilic statin use and risk of breast cancer subtypes. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2479-87.
    View in: PubMed
    Score: 0.008
  117. Trends in reporting of maternal drug abuse and infant mortality among drug-exposed infants in New York City. Women Health. 1990; 16(2):41-58.
    View in: PubMed
    Score: 0.007
  118. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women. Breast Cancer Res. 2009; 11(4):R51.
    View in: PubMed
    Score: 0.007
  119. Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol. 2009 Jul 01; 27(19):3211-6.
    View in: PubMed
    Score: 0.007
  120. Longitudinal association of anthropometry with mammographic breast density in the Study of Women's Health Across the Nation. Int J Cancer. 2009 Mar 01; 124(5):1169-77.
    View in: PubMed
    Score: 0.007
  121. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut. 2009 Feb; 58(2):182-8.
    View in: PubMed
    Score: 0.007
  122. Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study. Am J Gastroenterol. 2008 Dec; 103(12):2997-3004.
    View in: PubMed
    Score: 0.007
  123. Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter. 2008 Oct; 13(5):352-60.
    View in: PubMed
    Score: 0.007
  124. Hemochromatosis gene status as a risk factor for Barrett's esophagus. Dig Dis Sci. 2008 Dec; 53(12):3095-102.
    View in: PubMed
    Score: 0.007
  125. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008 Apr 16; 100(8):597-8; author reply 599.
    View in: PubMed
    Score: 0.007
  126. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst. 2008 Apr 16; 100(8):563-71.
    View in: PubMed
    Score: 0.007
  127. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut. 2008 Jun; 57(6):727-33.
    View in: PubMed
    Score: 0.006
  128. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008 Jun; 109(3):573-9.
    View in: PubMed
    Score: 0.006
  129. The association between mammographic breast density and bone mineral density in the study of women's health across the nation. Ann Epidemiol. 2007 Aug; 17(8):575-83.
    View in: PubMed
    Score: 0.006
  130. Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women. Menopause. 2007 May-Jun; 14(3 Pt 1):391-6.
    View in: PubMed
    Score: 0.006
  131. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007 Jul; 133(1):34-41; quiz 311.
    View in: PubMed
    Score: 0.006
  132. NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control. 2007 Aug; 18(6):613-20.
    View in: PubMed
    Score: 0.006
  133. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006 May; 101(5):937-44.
    View in: PubMed
    Score: 0.006
  134. Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat. 2006 Sep; 99(1):47-57.
    View in: PubMed
    Score: 0.006
  135. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol. 2004 May; 68(1):57-69.
    View in: PubMed
    Score: 0.005
  136. Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol. 2002 Oct; 12(7):469-75.
    View in: PubMed
    Score: 0.005
  137. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology. 2002 Mar; 122(3):633-40.
    View in: PubMed
    Score: 0.004
  138. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA. 1995 Jul 12; 274(2):137-42.
    View in: PubMed
    Score: 0.003
  139. Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts. J Infect Dis. 1995 Jul; 172(1):11-8.
    View in: PubMed
    Score: 0.003
  140. Diet and genital warts: a case-control study. Sex Transm Dis. 1994 May-Jun; 21(3):149-54.
    View in: PubMed
    Score: 0.003
  141. Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring. J Pediatr. 1993 Jul; 123(1):120-6.
    View in: PubMed
    Score: 0.002

© 2024 Kaiser Permanente